New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2014
07:17 EDTHZNPHorizon Pharma price target raised to $25 from $18 at Stifel
Stifel increased its price target on Horizon as the firm thinks that the company's acquisition of Vidara has left it in "ideal position" to become profitable and meet its revenue and EBITDA guidance. The firm thinks the company's drug portfolio is poised to perform well, and keeps a Buy rating on the shares.
News For HZNP From The Last 14 Days
Check below for free stories on HZNP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
10:00 EDTHZNPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:43 EDTHZNPHorizon Pharma downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
July 28, 2014
13:03 EDTHZNPHorizon Pharma shares offer 'significant value,' says Stifel
Subscribe for More Information
12:21 EDTHZNPOn The Fly: Midday Wrap
Subscribe for More Information
09:17 EDTHZNPOn The Fly: Pre-market Movers
Subscribe for More Information
06:22 EDTHZNPHorizon Pharma said Duexis, Vimovo to be placed on CVS, Express exlclusion lists
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use